Counsyl offered its hereditary cancer panel for free to San Francisco women and found that about half who had positive results would not have been screened.
The company said it plans to offer the underwriters of the offering an option to buy an additional 525,000 shares of its stock at the public offering price.
The new study will evaluate how different assays measuring PD-L1 expression compare to one another, an issue raised in recently published research.
TwoXar's business is based on licensing drug candidates to pharma identified using proprietary algorithms for exploring disease-compound associations.
PDI said that the workforce reduction would save $400,000 in December, and shave $1.9 million off of its annual operating costs going forward.
In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.
Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.
Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.
Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.